These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Dropping a dress size or seeing the numbers fall on the scales seems to be the talk of the town as of late - especially since ...

Lilly has said it plans to “gradually increase” the mainland commercial launch of bestseller Mounjaro. Going forward, “you’ll see a lot more competitors in the China market versus anywhere else,” said ...

This segment is sponsored by Eli Lilly and Company.Eric Stonestreet, the two-time Emmy-winning actor has many millions laught ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

More than a dozen Houston medical professionals and health care business owners were charged as part of a nationwide ...

New Delhi: India plans to roll-out a nationwide screening programme for measuring obesity among school children officials aware of the matter said. Children will be measured for their waist-to-hip ...